Bio-Techne Corporation
US ˙ NasdaqGS ˙ US09073M1045

SecurityTECH / Bio-Techne Corporation
InstitutionUbs Asset Management Americas Inc
Latest Disclosed Ownership439,373 shares
Latest Disclosed Value $ 22,961,634
Ubs Asset Management Americas Inc reports 3.95% increase in ownership of TECH / Bio-Techne Corporation

On May 13, 2026 - Ubs Asset Management Americas Inc filed a 13F-HR form disclosing ownership of 439,373 shares of Bio-Techne Corporation (US:TECH) valued at $22,961,633 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 422,679 shares of Bio-Techne Corporation. This represents a change in shares of 3.95% during the quarter. The current value of the position is $22,843,002 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F BIO-TECHNE COM 09073M104 439,373 16,694 3.95 22,962 -7.63 0.0007
2026-02-13 2025-12-31 13F BIO-TECHNE COM 09073M104 422,679 -133,253 -23.97 24,858 -19.62 0.0053
2025-11-14 2025-09-30 13F BIO-TECHNE COM 09073M104 555,932 -262,206 -32.05 30,926 -26.53 0.0067
2025-08-14 2025-06-30 13F BIO-TECHNE COM 09073M104 818,138 -126,189 -13.36 42,093 -23.97 0.0085
2025-05-19 2025-03-31 13F BIO-TECHNE COM 09073M104 944,327 19,606 2.12 55,366 -16.88 0.0142
2025-02-14 2024-12-31 13F BIO-TECHNE COM 09073M104 924,721 170,377 22.59 66,608 10.47 0.0155
2024-11-14 2024-09-30 13F BIO-TECHNE COM 09073M104 754,344 20,277 2.76 60,295 14.64 0.0155
2024-08-14 2024-06-30 13F BIO TECHNE COM 09073M104 734,067 191,096 35.19 52,596 37.61 0.0151
2024-05-15 2024-03-31 13F BIO TECHNE EQUITY US CM 09073M104 542,971 -14,113 -2.53 38,220 -11.09 0.0136
2024-02-14 2023-12-31 13F BIO TECHNE EQUITY US CM 09073M104 557,084 360 0.06 42,985 13.43 0.0169
2023-11-13 2023-09-30 13F BIO TECHNE EQUITY US CM 09073M104 556,724 96,922 21.08 37,896 11.09 0.0170
2023-08-11 2023-06-30 13F BIO TECHNE EQUITY US CM 09073M104 459,802 0 0.00 34,113 0.00 0.0165
2023-05-15 2023-03-31 13F BIO TECHNE EQUITY US CM 09073M104 459,802 -217 -0.05 34,113 -10.53 0.0165
2023-02-14 2022-12-31 13F BIO TECHNE EQUITY US CM 09073M104 460,019 342,754 292.29 38,126 14.48 0.0200
2022-11-14 2022-09-30 13F BIO TECHNE EQUITY US CM 09073M104 117,265 -17,354 -12.89 33,303 -28.63 0.0187
2022-08-12 2022-06-30 13F BIO TECHNE EQUITY US CM 09073M104 134,619 -8,980 -6.25 46,664 -24.96 0.0244
2022-05-16 2022-03-31 13F BIO TECHNE EQUITY US CM 09073M104 143,599 3,029 2.15 62,184 -14.49 0.0266
2022-02-14 2021-12-31 13F BIO TECHNE EQUITY US CM 09073M104 140,570 2,740 1.99 72,722 8.88 0.0278
2021-11-15 2021-09-30 13F BIO TECHNE EQUITY US CM 09073M104 137,830 9,897 7.74 66,788 15.95 0.0277
2021-08-16 2021-06-30 13F BIO TECHNE EQUITY US CM 09073M104 127,933 47,364 58.79 57,603 87.20 0.0246
2021-05-14 2021-03-31 13F BIO TECHNE EQUITY US CM 09073M104 80,569 591 0.74 30,772 21.16 0.0136
2021-03-01 2020-12-31 13F/A-1 BIO TECHNE EQUITY US CM 09073M104 79,978 11,204 16.29 25,397 49.07 0.0119
2021-02-17 2020-12-31 13F BIO TECHNE EQUITY US CM 09073M104 68,774 0 17,037 1.6069
2020-11-13 2020-09-30 13F BIO TECHNE EQUITY US CM 09073M104 68,774 2,529 3.82 17,037 -2.61 0.0092
2020-08-14 2020-06-30 13F BIO TECHNE EQUITY US CM 09073M104 66,245 12,963 24.33 17,493 73.15 0.0107
2020-05-15 2020-03-31 13F BIO TECHNE EQUITY US CM 09073M104 53,282 5,646 11.85 10,103 -3.38 0.0073
2020-02-14 2019-12-31 13F BIO TECHNE EQUITY US CM 09073M104 47,636 -239 -0.50 10,457 11.63 0.0064
2019-11-14 2019-09-30 13F BIO TECHNE EQUITY US CM 09073M104 47,875 3,123 6.98 9,368 0.40 0.0063
2019-08-15 2019-06-30 13F BIO TECHNE EQUITY US CM 09073M104 44,752 2,165 5.08 9,330 10.35 0.0067
2019-05-14 2019-03-31 13F BIO TECHNE EQUITY US CM 09073M104 42,587 6,877 19.26 8,456 63.63 0.0063
2019-02-13 2018-12-31 13F BIO TECHNE EQUITY US CM 09073M104 35,710 208 0.59 5,168 -28.69 0.0045
2018-11-13 2018-09-30 13F BIO TECHNE EQUITY US CM 09073M104 35,502 2,713 8.27 7,246 49.37 0.0054
2018-08-14 2018-06-30 13F BIO TECHNE EQUITY US CM 09073M104 32,789 65 0.20 4,851 -1.84 0.0037
2018-05-14 2018-03-31 13F BIO TECHNE EQUITY US CM 09073M104 32,724 1,917 6.22 4,943 23.83 0.0039
2018-02-09 2017-12-31 13F BIO TECHNE EQUITY US CM 09073M104 30,807 -1,657 -5.10 3,991 1.71 0.0034
2017-11-13 2017-09-30 13F BIO TECHNE EQUITY US CM 09073M104 32,464 4,159 14.69 3,925 18.02 0.0036
2017-08-11 2017-06-30 13F BIO TECHNE EQUITY US CM 09073M104 28,305 4,081 16.85 3,326 35.05 0.0032
2017-05-04 2017-03-31 13F BIO TECHNE EQUITY US CM 09073M104 24,224 2,453 11.27 2,462 10.01 0.0025
2017-03-09 2016-12-31 13F/A-1 BIO TECHNE COM 09073M104 21,771 -9,098 -29.47 2,238 -33.79 0.0025
2017-02-14 2016-12-31 13F BIO TECHNE COM 09073M104 21,771 2,238
2016-11-04 2016-09-30 13F BIO-TECHNE EQUITY US CM 09073M104 30,869 500 1.65 3,380 -1.31 0.0036
2016-11-29 2016-06-30 13F/A-1 BIO-TECHNE EQUITY US CM 09073M104 30,369 1,235 4.24 3,425 24.36 0.0039
2016-08-09 2016-06-30 13F BIO-TECHNE EQUITY US CM 09073M104 30,369 3,425
2016-05-12 2016-03-31 13F BIO-TECHNE EQUITY US CM 09073M104 29,134 -3,789 -11.51 2,754 -7.05 0.0032
2016-02-12 2015-12-31 13F BIO-TECHNE EQUITY US CM 09073M104 32,923 740 2.30 2,963 -0.44 0.0034
2015-10-29 2015-09-30 13F BIO-TECHNE EQUITY US CM 09073M104 32,183 8,246 34.45 2,976 26.26 0.0033
2015-08-12 2015-06-30 13F BIO-TECHNE EQUITY US CM 09073M104 23,937 1,887 8.56 2,357 6.60 0.0023
2015-05-04 2015-03-31 13F BIO-TECHNE EQUITY US CM 09073M104 22,050 22,050 2,211 0.0021
2015-02-02 2014-12-31 13F TECHNE EQUITY US CM 878377100 0 -20,850 -100.00 0 -100.00
2014-10-28 2014-09-30 13F TECHNE EQUITY US CM 878377100 20,850 400 1.96 1,951 3.06 0.0019
2014-08-13 2014-06-30 13F TECHNE EQUITY US CM 878377100 20,450 0 0.00 1,893 8.42 0.0019
2014-05-23 2014-03-31 13F TECHNE EQUITY US CM 878377100 20,450 4,200 25.85 1,746 13.52 0.0019
2014-01-31 2013-12-31 13F TECHNE EQUITY US CM 878377100 16,250 800 5.18 1,538 24.33 0.0018
2013-11-08 2013-09-30 13F TECHNE EQUITY US CM 878377100 15,450 0 0.00 1,237 15.82 0.0015
2013-08-15 2013-06-30 13F/A-1 TECHNE EQUITY US CM 878377100 15,450 15,450 1,068 0.0014
2013-08-13 2013-06-30 13F TECHNE EQUITY US CM 878377100 15,450 1,068 0.0014
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.